Credit Suisse Group Analysts Give Gerresheimer (ETR:GXI) a €84.00 Price Target

Share on StockTwits

Credit Suisse Group set a €84.00 ($97.67) target price on Gerresheimer (ETR:GXI) in a report issued on Monday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Other research analysts have also issued reports about the company. DZ Bank lowered NVIDIA to a sell rating and set a $170.00 price objective on the stock. in a research report on Friday, April 12th. HSBC decreased their price objective on WPP from GBX 1,000 ($13.07) to GBX 970 ($12.67) and set a hold rating on the stock in a research report on Thursday, July 4th. Deutsche Bank decreased their price objective on from GBX 217 ($2.84) to GBX 175 ($2.29) and set a sell rating on the stock in a research report on Monday, June 24th. Independent Research set a €72.00 ($83.72) price objective on Gerresheimer and gave the company a neutral rating in a research report on Friday, April 12th. Finally, Berenberg Bank reiterated a sell rating and issued a GBX 600 ($7.84) price objective on shares of Great Portland Estates in a research report on Wednesday, May 22nd. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. Gerresheimer has a consensus rating of Hold and a consensus target price of €69.17 ($80.43).

GXI stock traded up €8.95 ($10.41) during midday trading on Monday, reaching €74.00 ($86.05). 450,688 shares of the company’s stock traded hands, compared to its average volume of 140,925. The business has a 50-day moving average of €64.81. Gerresheimer has a 1-year low of €51.10 ($59.42) and a 1-year high of €80.25 ($93.31). The stock has a market cap of $2.32 billion and a P/E ratio of 12.96. The company has a current ratio of 0.78, a quick ratio of 0.51 and a debt-to-equity ratio of 68.19.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

See Also: Differences Between Momentum Investing and Long Term Investing

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.